Trial · NCT07898735
Applying of Absorbable Dressing (Reso-Pac) on the Palatal Donor Site
NCT07898735, Not applicable, Completed, Damascus University
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Applying of Absorbable Dressing (Reso-Pac) on the Palatal Donor Site. Trials, record NCT07898735. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07898735
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Applying of Absorbable Dressing (Reso-Pac) on the Palatal Donor Site
- NCT number
- NCT07898735
- Status
- Completed
- Phases
- Not applicable
- Enrollment
- 20 participants, actual
- Lead sponsor
- Damascus University
- Conditions
- Keratinized Tissue Deficiency
- Interventions
- Control group : Coe-pak, Study Group: Reso-pac
- First posted
- 2026-10-27
- Last updated
- 2026-10-27
Source ClinicalTrials.gov
Registered outcomes1
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Outcome MeasuresTitle: Pain Index | Time frame :T1: Day 1 post-surgery , T2 : Day 2 Post-surgery , T3: Day 3 post-surgery , T4: Day 4 post-surgery , T5: Day 5 post-surgery , T6: Day 6 post-surgery, Time Final: Day 7 post-surgery.. | The Visual Analog Scale (VAS) was used to assess patients' pain and discomfort daily for one week following treatment. The patient was given a sheet containing a pain scale on which to record their pain level daily. This scale was divided into 100-millimeter increments; a score of 0 at the left end of the scale indicated no pain, while a score of 100 at the right end indicated unbearable pain. |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers4
The papers the trial lists on ClinicalTrials.gov.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07898735
GET https://conductscience.org/api/trials/v1/NCT07898735/registered